These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33517680)

  • 1. Association of Self-Reported Polycystic Ovary Syndrome, Obesity, and Weight Gain From Adolescence to Adulthood With Hypertensive Disorders of Pregnancy: A Community-Based Approach.
    Rantakallio JSS; Nevalainen JE; West SI; Ollila MM; Puukka K; Bloigu AH; Järvelin MR; Tapanainen JS; Franks S; Dunkel L; Piltonen TT; Vääräsmäki MS; Morin-Papunen LC
    Hypertension; 2021 Mar; 77(3):1010-1019. PubMed ID: 33517680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight, obesity and hyperandrogenemia are associated with gestational diabetes mellitus: A follow-up cohort study.
    West S; Ollila MM; Franks S; Piltonen T; Jokelainen J; Nevalainen J; Puukka K; Ruokonen A; Järvelin MR; Auvinen J; Tapanainen JS; Morin-Papunen L
    Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1311-1319. PubMed ID: 32333801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.
    Ollila ME; Kaikkonen K; Järvelin MR; Huikuri HV; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen L
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1221-1231. PubMed ID: 30445634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study.
    Ollila MM; Piltonen T; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Morin-Papunen L
    J Clin Endocrinol Metab; 2016 Feb; 101(2):739-47. PubMed ID: 26652764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
    Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMI in childhood and adolescence is associated with impaired reproductive function-a population-based cohort study from birth to age 50 years.
    Laru J; Nedelec R; Koivuaho E; Ojaniemi M; Järvelin MR; Tapanainen JS; Franks S; Tolvanen M; Piltonen TT; Sebert S; Morin-Papunen L
    Hum Reprod; 2021 Oct; 36(11):2948-2961. PubMed ID: 34364312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.
    West S; Vähäsarja M; Bloigu A; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Corbett S; Vääräsmäki M; Morin-Papunen L
    Hum Reprod; 2014 Mar; 29(3):628-33. PubMed ID: 24324025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy.
    Lønnebotn M; Natvig GK; Benediktsdóttir B; Burgess JA; Holm M; Jógi R; Lindberg E; Macsali F; Schlünssen V; Skulstad SM; Franklin KA; Vanky E; Gòmez Real F
    Pregnancy Hypertens; 2018 Jan; 11():32-37. PubMed ID: 29523270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression.
    Pan H; Xian P; Yang D; Zhang C; Tang H; He X; Lin H; Wen X; Ma H; Lai M
    Endocrine; 2021 Dec; 74(3):518-529. PubMed ID: 34655376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of hypertensive disorders in pregnancy in women with and without polycystic ovary syndrome: The Australian Longitudinal Study of Women's Health.
    Bahri Khomami M; Earnest A; Loxton D; Teede HJ; Joham AE
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):323-331. PubMed ID: 33639011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms.
    Laitinen J; Taponen S; Martikainen H; Pouta A; Millwood I; Hartikainen AL; Ruokonen A; Sovio U; McCarthy MI; Franks S; Järvelin MR
    Int J Obes Relat Metab Disord; 2003 Jun; 27(6):710-5. PubMed ID: 12833115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.
    Chen X; Koivuaho E; Piltonen TT; Gissler M; Lavebratt C
    Hum Reprod; 2021 Jul; 36(8):2345-2357. PubMed ID: 34046665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study.
    Barrett PM; McCarthy FP; Evans M; Kublickas M; Perry IJ; Stenvinkel P; Khashan AS; Kublickiene K
    PLoS Med; 2020 Aug; 17(8):e1003255. PubMed ID: 32797043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
    Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
    Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study.
    Foroozanfard F; Asemi Z; Bazarganipour F; Taghavi SA; Allan H; Aramesh S
    Gynecol Endocrinol; 2020 Jan; 36(1):61-65. PubMed ID: 31264483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study.
    Chen X; Kong L; Piltonen TT; Gissler M; Lavebratt C
    Hum Reprod; 2020 Oct; 35(10):2336-2347. PubMed ID: 32866965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort.
    Schneider D; Gonzalez JR; Yamamoto M; Yang J; Lo JC
    J Pregnancy; 2019; 2019():9847057. PubMed ID: 30693108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.